MEDIGENE IMMUNOTHERAPIES
USPTO Trademark Record · Serial No. 86605899
Trademark details
It was initially claimed by Medigene Immunotherapies GmbH on 20150422.
That brand applies to the following goods and services:Medicines for humans and animals for the treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, vaccines, medicated serums for treatment of tumor precursors, benign and malignant tumor diseases, particularly hematological tumor diseases, inflammatory diseases, neurodegenerative diseases, and autoimmune diseases, diagnostic and drug testing kits comprised of medical, Services of a molecular biology or biotechnology laboratory, particularly research and development work in the field of human medical and veterinary medical diagnosis and therapy by means of molecular biology, genetic engineering or biotechnological methods as well as in the field of screening for pharmaceutically active compounds; design and development of test methods and test kits in the field of biotechnology and medicine, Medical analyses and medical consultancy in the context of the treatment of single persons, particularly in the field of tumor precursors, benign and malignant tumor diseases, autoimmune diseases and immunotherapy, Licensing of intellectual property, including trademarks and patents in the field of biotechnology, pharmacy, and medicine.
Currently that trademark is represented by trademark attorney(s): Gwynne B. Sugg.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the MEDIGENE IMMUNOTHERAPIES trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
